BBIO (STOCKS)
BridgeBio Pharma, Inc. Common Stock
$73.510000
+1.040000 (+1.44%)
Prev close: $72.470000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Neil Kumar
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $15,047.15M
- Employees
- 730
- P/E (TTM)
- -17.51
- P/B (TTM)
- -7.31
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $235.81M |
| Benefits Costs and Expenses | $1.02B |
| Cost Of Revenue | $8.97M |
| Costs And Expenses | $892.24M |
| Gross Profit | $226.84M |
| Nonoperating Income/Loss | -$125.33M |
| Operating Expenses | $883.27M |
| Selling, General, and Administrative Expenses | $399.12M |
| Research and Development | $473.46M |
| Other Operating Expenses | $10.69M |
| Operating Income/Loss | -$656.43M |
| Income/Loss Before Equity Method Investments | -$722.75M |
| Income/Loss From Continuing Operations After Tax | -$785.01M |
| Income/Loss From Continuing Operations Before Tax | -$781.76M |
| Income/Loss From Equity Method Investments | -$59.00M |
| Income Tax Expense/Benefit | $3.25M |
| Net Income/Loss | -$785.01M |
| Net Income/Loss Attributable To Noncontrolling Interest | -$8.59M |
| Net Income/Loss Attributable To Parent | -$776.42M |
| Net Income/Loss Available To Common Stockholders, Basic | -$776.42M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$4.12 |
| Diluted Earnings Per Share | -$4.12 |
| Basic Average Shares | 379,971,333 |
| Diluted Average Shares | 379,971,333 |
| Assets | $1.08B |
| Current Assets | $912.28M |
| Inventory | $18.28M |
| Other Current Assets | $894.00M |
| Noncurrent Assets | $167.91M |
| Fixed Assets | $6.11M |
| Intangible Assets | $29.51M |
| Other Non-current Assets | $132.29M |
| Liabilities | $2.86B |
| Current Liabilities | $175.85M |
| Accounts Payable | $26.13M |
| Wages | $37.19M |
| Other Current Liabilities | $112.53M |
| Noncurrent Liabilities | $2.68B |
| Equity | -$1.78B |
| Equity Attributable To Noncontrolling Interest | $9.89M |
| Equity Attributable To Parent | -$1.79B |
| Liabilities And Equity | $1.08B |
| Net Cash Flow From Operating Activities | -$655.81M |
| Net Cash Flow From Operating Activities, Continuing | -$655.81M |
| Net Cash Flow From Investing Activities | $20.39M |
| Net Cash Flow From Investing Activities, Continuing | $20.39M |
| Net Cash Flow From Financing Activities | $837.01M |
| Net Cash Flow From Financing Activities, Continuing | $837.01M |
| Net Cash Flow | $201.59M |
| Net Cash Flow, Continuing | $201.59M |
| Comprehensive Income/Loss | -$785.00M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | -$8.59M |
| Comprehensive Income/Loss Attributable To Parent | -$776.41M |
| Other Comprehensive Income/Loss | $5.00K |